Sustained release pharmaceutical composition

Details Sustained release pharmaceutical composition Sustained release pharmaceutical composition

1975-12-01

1979-12-11

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Polymer from ethylenic monomers only

424 81, A61K 922

Patent

active

041783611

ABSTRACT:
A sustained release pharmaceutical composition which includes a pharmacological material; a biological binding agent for the pharmacological material; and a matrix of a water-insoluble but water-swellable hydrophilic polymer.

REFERENCES:
patent: 2659732 (1953-11-01), Cusic et al.
patent: 2776299 (1957-01-01), Cusic et al.
patent: 2830930 (1958-04-01), Olinger
patent: 3232833 (1966-01-01), Riviere
patent: 3551556 (1970-12-01), Kliment et al.
patent: 3577512 (1971-05-01), Shepherd et al.
patent: 3584113 (1971-06-01), Takebe et al.
patent: 3641237 (1972-02-01), Gould et al.
patent: 3673612 (1972-07-01), Merrill et al.
patent: 3765414 (1973-10-01), Arlen
patent: 3826678 (1974-07-01), Hoffman et al.
patent: 3844989 (1974-10-01), Harumiya et al.
Stecher et al., Merck Index, 8th ed., 1968, p. 671, "Methantheline Bromide".

Affiliated with

Also associated with

Rating

Sustained release pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-310814